Opportunity Information: Apply for CDC RFA PS13 1315
Apply for CDC RFA PS13 1315
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient centered HIV Care" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941 HIV Demonstration, Research, Public and Professional Education Projects.
- This funding opportunity was created on Apr 8, 2013 and posted on Apr 1, 2013.
- Applicants must submit their applications by May 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,300,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- 1. Eligible Applicants American Indian/Alaska Native tribal governments (federally recognized or state recognized) American Indian/Alaska native tribally designated organizations Alaska Native health corporations Colleges Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Political subdivisions of States (in consultation with States) Research institutions (that will perform activities deemed as non research) Small, minority, and women owned businesses State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . Tribal epidemiology centers Universities Urban Indian health organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, issued by the Centers for Disease Control and Prevention (CDC) as a discretionary cooperative agreement (Funding Opportunity Number CDC RFA PS13-1315), focuses on improving HIV prevention and treatment outcomes for people living with HIV by integrating community pharmacists and clinical care sites into a patient-centered model of HIV care. The central idea is that HIV care has changed dramatically over the past two decades. Where HIV was once managed largely as an acute, life-threatening illness handled primarily by infectious disease specialists, advances in antiretroviral therapy (ART) have turned HIV into a chronic, manageable condition for many patients. That success, however, has created a new set of practical care challenges that require broader, more coordinated support than the traditional specialist-centered model often provides.
The announcement explains that today’s HIV care is increasingly complex because patients are living longer and are more likely to experience co-morbid conditions alongside HIV. Providers must manage long-term ART, monitor and address medication side effects, and prevent or resolve clinically significant drug-drug interactions. At the same time, people living with HIV face an increased risk of age-associated, non-AIDS-related illness and mortality, which means clinical teams must pay attention not only to viral suppression but also to whole-person health needs over time. In this context, the grant opportunity proposes that community pharmacists can play a more integrated role with clinical sites to strengthen medication management and continuity of care, reducing gaps that can occur when treatment regimens are complicated and patients interact with multiple parts of the healthcare system.
In practical terms, the opportunity supports a model of patient-centered HIV care that formally connects community-based pharmacy services with HIV clinical care settings. Community pharmacists are positioned to contribute to adherence support, medication counseling, identification of potential interactions (including with medications for other chronic conditions), monitoring issues related to side effects and tolerability, and reinforcing prevention-related messages and behaviors as part of routine medication touchpoints. By tying pharmacists more closely to clinical sites, the model aims to improve communication, coordination, and follow-through, which are essential for maintaining viral suppression and preventing avoidable complications. The overall emphasis is on improving HIV-related outcomes by strengthening the care team around the patient, rather than leaving medication-related challenges to be addressed only during periodic clinic visits.
The funding mechanism is a cooperative agreement, which generally indicates substantial federal involvement or collaboration in the funded project’s implementation compared with a standard grant. The total estimated funding amount listed is $2.3 million, with an award ceiling of $2.3 million, and the CDC expected to make one award under this announcement. There is no cost-sharing or matching requirement. The program is associated with CFDA number 93.941, described as HIV Demonstration, Research, Public and Professional Education Projects, suggesting the work is intended to demonstrate and operationalize an improved service model and generate practical lessons that can inform broader practice.
Eligibility is broad and includes many types of organizations that could realistically build partnerships between pharmacists and clinical providers. Eligible applicants include state and local governments and their agents, tribal governments and tribal organizations, urban Indian health organizations, colleges and universities, hospitals, community-based and faith-based organizations, research institutions (for activities considered non-research under the award), nonprofit organizations with or without 501(c)(3) status, and certain for-profit entities (other than small businesses), as well as small, minority-, and women-owned businesses. This wide eligibility reflects the fact that effective HIV care coordination can be led by public health departments, healthcare systems, academic entities, or community organizations, depending on local infrastructure and patient needs.
Key administrative details from the listing include a posted date of April 1, 2013, with an original and current closing date of May 15, 2013, and an archive date of June 14, 2013. The CDC Procurement and Grants Office is listed as the contact point for accessing the full announcement if needed. Overall, the opportunity is designed to support a single, well-resourced demonstration that operationalizes a patient-centered HIV care approach by deliberately integrating community pharmacists with clinical HIV care sites, addressing the modern realities of long-term HIV management: adherence challenges, complex drug regimens, co-morbidities, side effects, interactions, and aging-related health risks.
Frequently Asked Questions (FAQs)
What is the purpose of this CDC funding opportunity?
The purpose is to improve HIV prevention and treatment outcomes for people living with HIV by integrating community pharmacists and clinical care sites into a patient-centered model of HIV care. The model is designed to strengthen medication management and continuity of care in response to the modern realities of long-term HIV treatment.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is CDC RFA PS13-1315.
Which federal agency is offering this opportunity?
This opportunity is issued by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is being used?
The funding mechanism is a discretionary cooperative agreement, which generally indicates substantial federal involvement or collaboration in the funded project compared with a standard grant.
How much funding is available under this opportunity?
The total estimated funding amount is $2.3 million, and the award ceiling is also $2.3 million.
How many awards does CDC expect to make?
CDC expected to make one award under this announcement.
Is cost-sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
What is the core idea behind integrating community pharmacists into HIV care?
HIV care has shifted over the past two decades from an acute, life-threatening illness managed primarily by specialists to a chronic, manageable condition for many patients due to advances in antiretroviral therapy (ART). That success has introduced new care coordination challenges, including long-term medication management, co-morbidities, side effects, and drug-drug interactions. Community pharmacists are positioned to support patients more routinely and help clinical sites maintain strong medication-related follow-through between clinic visits.
What patient needs is this model intended to address?
The model is intended to address challenges associated with long-term ART and chronic HIV management, including adherence support, monitoring and addressing side effects and tolerability, preventing or resolving clinically significant drug-drug interactions, and supporting whole-person health needs as people with HIV live longer and face age-associated, non-AIDS-related illness and mortality risks.
What roles can community pharmacists play in this patient-centered HIV care model?
As described in the announcement, community pharmacists can contribute by supporting adherence, providing medication counseling, identifying potential drug-drug interactions (including interactions involving medications for other chronic conditions), monitoring issues related to side effects and tolerability, and reinforcing prevention-related messages and behaviors during routine medication touchpoints.
How does the model improve communication and coordination between pharmacy and clinical care?
The opportunity supports formally connecting community-based pharmacy services with HIV clinical care settings. By tying pharmacists more closely to clinical sites, the model aims to improve communication, coordination, and follow-through to reduce gaps that can occur when regimens are complicated and patients interact with multiple parts of the healthcare system.
Who is the intended population served by this project?
The intended population is people living with HIV, with an emphasis on improving prevention and treatment outcomes through better coordinated, patient-centered HIV care.
What outcomes is the project trying to improve?
The opportunity emphasizes improving HIV-related outcomes by strengthening the care team around the patient, supporting continuity of care, and addressing medication-related challenges that can affect viral suppression and contribute to avoidable complications.
What is the CFDA number associated with this program?
The program is associated with CFDA number 93.941, described as HIV Demonstration, Research, Public and Professional Education Projects.
Does the opportunity indicate whether the work is meant to be a demonstration project?
Yes. The CFDA description and the announcement framing indicate the work is intended to demonstrate and operationalize an improved service model and generate practical lessons that can inform broader practice.
Who is eligible to apply for this funding?
Eligibility is broad and includes: state and local governments and their agents; tribal governments and tribal organizations; urban Indian health organizations; colleges and universities; hospitals; community-based and faith-based organizations; research institutions (for activities considered non-research under the award); nonprofit organizations with or without 501(c)(3) status; certain for-profit entities (other than small businesses); and small, minority-, and women-owned businesses.
Can nonprofit organizations without 501(c)(3) status apply?
Yes. The eligibility list includes nonprofit organizations with or without 501(c)(3) status.
Are for-profit organizations eligible to apply?
Yes, certain for-profit entities (other than small businesses) are included in the eligibility list, and the listing also mentions small, minority-, and women-owned businesses.
What are the key dates for this funding opportunity?
The posted date is April 1, 2013. The original and current closing date is May 15, 2013. The archive date is June 14, 2013.
Where can applicants find the full announcement or get official administrative guidance?
The CDC Procurement and Grants Office is listed as the contact point for accessing the full announcement if needed.
Why does the announcement emphasize co-morbidities and aging-related risks?
The announcement explains that as people with HIV live longer, they are more likely to experience co-morbid conditions alongside HIV and face increased risk of age-associated, non-AIDS-related illness and mortality. This increases the complexity of care and makes coordinated, long-term medication management and whole-person care more important.
How is this model different from a traditional specialist-centered HIV care approach?
The traditional approach often relies heavily on periodic clinic visits with specialists. This opportunity emphasizes a broader, coordinated support structure by integrating community pharmacists with clinical HIV care sites, aiming to address medication-related issues and adherence needs more continuously as part of routine pharmacy interactions.
What is the main strategy described for reducing gaps in HIV care?
The main strategy is strengthening the care team around the patient by deliberately integrating community pharmacists with HIV clinical care sites to improve coordination, communication, and follow-through on medication management and related support.
Browse more opportunities from the same category: Health
Next opportunity: Reading Enhancement for Advancing Development (READ) activity
Previous opportunity: FY 2013 Funding Opportunity Announcement for NGO programs benefiting urban refugees in Egypt
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 1315
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 1315) also looked into and applied for these:
| Funding Opportunity |
|---|
| Medical Professionals Recruitment and Continuing Education Programs Apply for HHS 2013 IHS HPR 0001 Funding Number: HHS 2013 IHS HPR 0001 Agency: Indian Health Service Category: Health Funding Amount: $25,000 |
| NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03) Apply for PAR 13 178 Funding Number: PAR 13 178 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Undiagnosed Diseases Gene Function Research (R21) Apply for RFA RM 13 003 Funding Number: RFA RM 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Implementation Science for Strengthening Use of Evidence in Family Planning/Reproductive Health Programming (ISSUE FP/RH) Apply for SOL OAA 13 000005 Funding Number: SOL OAA 13 000005 Agency: Agency for International Development Category: Health Funding Amount: $150,000,000 |
| Child, Newborn, and Maternal Health Project Apply for RFA 391 13 000009 Funding Number: RFA 391 13 000009 Agency: Pakistan USAID Islamabad Category: Health Funding Amount: Case Dependent |
| Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 13 179 Funding Number: PA 13 179 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Research Scientist Development Award (K01) Apply for PA 13 181 Funding Number: PA 13 181 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Clinical Investigator Award (K08) Apply for PA 13 180 Funding Number: PA 13 180 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Tyler, Texas Roxbury, Massachusetts and Bristol, Florida Apply for HRSA 13 277 Funding Number: HRSA 13 277 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Republic of Palau) Apply for PA FPH 13 041 Funding Number: PA FPH 13 041 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $145,000 |
| State Systems Development Initiative Grant Program Apply for HRSA 13 268 Funding Number: HRSA 13 268 Agency: Health Resources and Services Administration Category: Health Funding Amount: $25,000 |
| FaceBase 2 Craniofacial Development and Dysmorphology Dataset, Tool, and Resource Development (U01) Apply for RFA DE 14 004 Funding Number: RFA DE 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FaceBase 2 Craniofacial Development and Dysmorphology Data Management and Integration Hub (U01) Apply for RFA DE 14 005 Funding Number: RFA DE 14 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Occupational Safety and Health Research (R01) Apply for PAR 13 129 Funding Number: PAR 13 129 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Family Health Plus (FH ) Project Apply for RFA 620 13 000002 Funding Number: RFA 620 13 000002 Agency: Nigeria USAID Abuja Category: Health Funding Amount: $9,000,000 |
| Advancing Alcohol Screening and Brief Intervention (aSBI) and CHOICES in American Indian and Alaska Native Populations through Training and Technical Assistance Apply for CDC RFA DD13 1301 Funding Number: CDC RFA DD13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| PPHF 2013 Cooperative Agreement to Support Navigators in Federally facilitated and State Partnership Exchanges Apply for CA NAV 13 001 Funding Number: CA NAV 13 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| STRENGTHENING RMNCH THROUGH INDIAN HEALTH PROFESSIONAL ASSOCIATIONS AND SCALING UP UPTAKE OF HEALTH, EDUCATIONAL, SOCIAL PROTECTION AND WELFARE INTERVENTIONS AMONG CHILDREN AFFECTED BY HIV/AIDS Apply for APS 386 13 000004 Funding Number: APS 386 13 000004 Agency: India USAID New Delhi Category: Health Funding Amount: $8,000,000 |
| NINDS Stroke Trials Network National Data Management Center (U01) Apply for RFA NS 13 016 Funding Number: RFA NS 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| NIDCD Research Career Enhancement Award for Established Investigators (K18) Apply for PAR 13 186 Funding Number: PAR 13 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 1315", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.